Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying results 1 - 10 of 10
Metabolism, Alcohol & Toxicity
On-demand Webinar: Steatotic liver disease – the missing piece in the NCD puzzle

On-demand Webinar: Steatotic liver disease – the missing piece in the NCD puzzle

On-demand Webinars
View
Metabolism, Alcohol & Toxicity
EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

Podcasts
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

Podcasts
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline - GE version

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline

Non-alcoholic fatty liver disease: A patient guideline

PDF
View
Metabolism, Alcohol & Toxicity
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
COVID-19 and the liver
Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Podcasts
View
Metabolism, Alcohol & Toxicity
Reducing the burden of alcohol-related liver disease (ARLD)

Reducing the burden of alcohol-related liver disease (ARLD)

Infographics
View
Metabolism, Alcohol & Toxicity
Obesity and non-alcoholic fatty liver disease (NAFLD)

Obesity and non-alcoholic fatty liver disease (NAFLD)

Infographics
View